Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosyl- phosphate-tetanus toxoid conjugate vaccine

Bulletin of the World Health Organization

Volumn 78, Issue 3, 2000, Pages 364-371

  Panpitpat, C ^a   Thisyakorn, U ^b   Chotpitayasunondh, T ^c   Furer E ^d   Que, J U ^d   Hasler, T ^d   Cryz Jr , S J ^d  

^a Udon Thani Center Hospital   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Bangkok Children's Hospital   (Thailand)

^d Berna Biotech AG   (Switzerland)

Author keywords

Diphtheria tetanus pertussis vaccine, antagonists and inhibitors; Drug antagonism; Haemophilus influenzae type B, immunology; Haemophilus vaccines, antagonists and inhibitors; Tetanus immunology, tetanus toxoid, antagonists and inhibitors; Thailand

Indexed keywords

BACTERIUM ANTIBODY; CARRIER PROTEIN; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DITEPER ANATOXAL BERNA; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MATERNAL ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; EDEMA; ERYTHEMA; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; NEWBORN TETANUS; NORMAL HUMAN; SKIN MANIFESTATION; TETANUS PROPHYLAXIS; THAILAND; VACCINATION;

AGE FACTORS; ASIA; BACTERIAL AND FUNGAL DISEASES; BIOLOGY; CLINICAL RESEARCH; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DIPHTHERIA; DISEASES; HEALTH; IMMUNITY; IMMUNOLOGICAL EFFECTS; INFANT; INFECTIONS; PERTUSSIS; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; PUBLIC HEALTH; RESEARCH METHODOLOGY; RESEARCH REPORT; RURAL POPULATION; SAFETY; SOUTHEASTERN ASIA; TETANUS; THAILAND; VACCINES; YOUTH;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; POLYSACCHARIDES, BACTERIAL; PREGNANCY; TETANUS TOXIN; VACCINES, CONJUGATE;

EID: 0034036720     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. Journal of Infectious Diseases, 1992, 165 (Suppl.): S20-S25.
2. Makela PH et al. Epidemiology of invasive Haemophilus influenzae type b disease. Journal of Infectious Diseases, 1992, 165 (Suppl.): S2-S6.
3. Moxon ER, Wilson R. The role of Haemophilus influenzae in the pathogenesis of pneumonia. Reviews of Infectious Diseases, 1991, 13 (Suppl.): S518-S527.
4. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet, 1992, 340: 592-594.
5. Shapiro ED, Ward JI. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiologic Reviews, 1991, 13: 113-142.
6. Claesson BA et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. Journal of Pediatrics, 1989, 114: 97-100.
7. Eskola J et al. Finnish efficacy trials with Haemophilus influenzae type b vaccines. Journal of Infectious Diseases, 1992, 165 (Suppl.): S137-S138.
8. Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. Journal of Pediatrics, 1992, 121: 355-362.
9. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994. Morbidity and Mortality Weekly Report, 1995, 44: 545-550.
10. Avendano A et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus, or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four, and six months of age. Pediatric Infectious Disease Journal, 1993, 12: 638-643.
11. Miller MA et al. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics, 1995, 95: 522-527.
12. Bijlmer HA. World-wide epidemiology of Haemophilus influenzae meningitis: industrialized versus non-industrialized countries. Vaccine, 1991, 9 (Suppl.): S5-S9.
13. Funkhouser A, Steinhoff MC, Ward J. Haemophilus influenzae disease and immunization in developing countries. Reviews of Infectious Diseases, 1991, 13 (Suppl. 6): S542-S554.
14. Chotpitayasunondh T. Bacterial meningitis in children: etiology and clinical features, an 11-year review of 618 cases. Southeast Asian Journal of Tropical Medicine and Public Health, 1994, 25: 107-115.
15. Barington T et al. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infection and Immunity, 1994, 62: 9-14.
16. Schneerson R et al. Preparation, characterization, and immunogenicity of Haemophilus Influenzae type b polysaccharide protein conjugates. Journal of Experimental Medicine, 1980, 152: 361.
17. Anderson P. The protective level of serum antibodies to the capsular polysaccharide antigen of Haemophilus Influenzae type B. Journal of Infectious Diseases, 1984, 149: 1034.
18. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1993. Morbidity and Mortality Weekly Report, 1994, 43: 144-148.
19. Black SB et al. Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheriatetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatric Infectious Disease Journal, 1993, 12: 981-985.
20. Paradiso PR et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics, 1993, 92: 827-832.
21. Barington T et al. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infection and Immunity, 1993, 61: 432-438.
22. Lieberman JM et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. Journal of Pediatrics, 1995, 126: 198-205.
23. Scheifele D et al. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Canadian Medical Association Journal, 1993, 149: 1105-1112.
24. Granoff DM et al. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. Journal of the American Medical Association, 1994, 272: 1116-1121.